Wes Streeting MP: speeches

Wes Streeting MP: full overview

4 Jul 2025–3 Jul 2026

How these years work

Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.

Compare reporting years, sessions and IPSA financial years.

Parliamentary contributions: dates and coverage

Source checked
19 Nov 2026
Last successful import
19 Nov 2026
Records dated through
18 Nov 2026
Selected period
Reporting year 2: 4 Jul 2025 to 3 Jul 2026
Completeness
Published snapshot: 20,988 records in the source window 21 Aug 2026 to 19 Nov 2026. The published snapshot covers its stated source window. Older imports can extend beyond it; not every public speech is included.

How to read these datesOfficial source

This page lists the parliamentary spoken contributions we hold for Wes Streeting in the reporting year 2 (4 Jul 2025 to 3 Jul 2026). It does not include every public speech, party-conference address or constituency event. Latest retained contribution in this period: 30 Jun 2026. The source check date and dataset limits are shown above. Open the Hansard link for the full debate and surrounding context.

Clear speech filters

Read what this MP said, asked and contributed in Parliament.

365 published records · newest first.

Speeches

  • 17 Dec 2025 · Puberty Suppressants Trial · Read the full contribution in Hansard
    More

    I first thank the right hon. Member for the way in which he puts his concerns. I know he is concerned about this trial and that he has stated publicly his opposition to it, and I enormously respect the way in which he has done that. These are finely balanced judgments, and I acknowledge that.

  • 17 Dec 2025 · Puberty Suppressants Trial · Read the full contribution in Hansard
    More

    I will take the hon. Member’s question in three parts. First, the opinion polling that she mentions shows that people in this country are overwhelmingly kind, and they want to ensure that trans people, and LGBT people more broadly, are treated with kindness, compassion and inclusion. Secondly, I do not dismiss the opinion polling that shows that a majority are against this kind of trial.

  • 17 Dec 2025 · Puberty Suppressants Trial · Read the full contribution in Hansard
    More

    The right hon. Member is right that we need that data linkage study. That will happen, but it will not produce the same evidence base as a clinical trial, and that is the distinction between the two. It is frankly a disgrace that people have sought to withhold that kind of data and it is really important that we get this right. I appreciate the right hon. Member’s sympathy.

  • 17 Dec 2025 · Puberty Suppressants Trial · Hansard source
    More

    They certainly can, and if they withdraw, they will still get the wider therapeutic support they deserve.

  • 17 Dec 2025 · Puberty Suppressants Trial · Read the full contribution in Hansard
    More

    The hon. Lady has offered a political opinion, not a clinical judgment. By that logic, we would not have any medicine for children and young people; we would never have undertaken clinical trials or studies, because we would have judged that children and young people could not take part in them. That is objectively not a sensible position. I understand the sensitivity surrounding this issue, and the hon.

  • 17 Dec 2025 · Puberty Suppressants Trial · Read the full contribution in Hansard
    More

    May I thank the hon. Member for the way in which he put his question? It is so important to emphasise that right across this House, there are many people who oppose this trial, but who do want to see trans people well supported and protected and to respect their identities. That is important for everyone to bear in mind. The hon. Member talks about placebo.

  • 17 Dec 2025 · Puberty Suppressants Trial · Read the full contribution in Hansard
    More

    I certainly do not need to be told what my responsibilities are on this. I always take responsibility for the decisions I take. I acknowledge the extent to which the hon. Gentleman and members of his party seek to weaponise this issue, and to personalise it. [ Interruption. ] We can simply refer back to his question and to the shadow Minister’s reference to the “Streeting trial”—if that is not personalising, I do not know what is.

  • 17 Dec 2025 · Puberty Suppressants Trial · Read the full contribution in Hansard
    More

    Let me reassure my hon. Friend and the House that I am absolutely open to receiving representations and evidence from clinicians involved in the care of children and young people, with insight, expertise and data, including those who might be critical of the approach that the trial team is setting out or, indeed, critical that the Cass review included this recommendation.

  • 17 Dec 2025 · Puberty Suppressants Trial · Hansard source
    More

    My hon. Friend is correct that the study is about building the right evidence so that we get high-quality, safe healthcare for this vulnerable group of children and young people.

  • 17 Dec 2025 · Puberty Suppressants Trial · Hansard source
    More

    My hon. Friend is absolutely right. Given that I work for a former Crown prosecutor, I could not possibly disagree with her on evidence.

  • 17 Dec 2025 · Puberty Suppressants Trial · Read the full contribution in Hansard
    More

    I wish I had certainty on this issue, and in some ways I envy my hon. Friend for his certainty. Having occasionally found myself to be a lonely voice in my party when sat on the Opposition Benches, I respect the fact that it is not easy to be a minority, dissenting voice, especially when one feels so strongly about an issue. I respect my hon.

  • 17 Dec 2025 · Puberty Suppressants Trial · Read the full contribution in Hansard
    More

    I can certainly promise my hon. Friend that we will keep the House regularly updated. The risks he has described have weighed heavily on my conscience when putting in place a permanent ban on puberty blockers; I have understood the risk involved, and the vulnerability of this particular group of children and young people. I also meant to say, in response to my hon.

  • 17 Dec 2025 · Puberty Suppressants Trial · Hansard source
    More

    My hon. Friend is absolutely right. Regardless of whether people are receiving this medication or not, we need to ensure that they receive the right therapeutic support to enable them to have healthy, happy childhoods and to understand themselves, the world they live in and how they relate to it in a way that does not cause them distress or harm. That is my objective in this process.

  • 17 Dec 2025 · Puberty Suppressants Trial · Read the full contribution in Hansard
    More

    I thank the right hon. Gentleman for his question and for how he puts his criticism, too. As I said earlier, and for the avoidance of doubt, I know what my responsibilities are. I understand the decisions that I take in this office and that I am accountable for those decisions. I do not resile from that. I am following clinical advice; I think that is the right thing to do in this area.

  • 17 Dec 2025 · Puberty Suppressants Trial · Read the full contribution in Hansard
    More

    I will try to do that, Madam Deputy Speaker. We will ensure that young people get good access to wider evidence-led support. I have had to wrestle with the fact that some trans people enter adulthood without ever receiving any sort of healthcare, and I have been heavily criticised by those people in particular for some of the decisions that I have taken. We are working to reduce waiting times, as I have described. My hon.

  • 17 Dec 2025 · Puberty Suppressants Trial · Hansard source
    More

    I assure the hon. Member that as part of this study, and as part of the roll-out of services across the country, we are focusing on the therapeutic support that she describes. We are implementing the Cass review, which recommended this particular trial for this particular purpose, and we will follow the evidence. Of course we look at what other countries are doing, why they are doing it and what research emerges.

  • 17 Dec 2025 · Puberty Suppressants Trial · Read the full contribution in Hansard
    More

    As I reported when we put in place the permanent ban, there have been arrangements for people who were previously being prescribed puberty blockers. People who wanted to access them, but could not once the ban came in, have not been able to do so through authorised means.

  • 17 Dec 2025 · Puberty Suppressants Trial · Read the full contribution in Hansard
    More

    My hon. Friend is absolutely right that we must engage with due care and sensitivity on this issue. I can share with the House that these exchanges, Government policy, what is said by me and others, are followed extremely closely by this group of children and young people, who are extremely online, and by the wider LGBT+ community. My hon.

  • 17 Dec 2025 · Puberty Suppressants Trial · Read the full contribution in Hansard
    More

    When it was published—I was in the Chamber at the time—there was an overwhelming consensus in the House. There were some people who criticised and challenged the Cass review at the time, including some outside the House in the LGBT community. I have always supported the Cass review, which was led by one of our country’s best paediatricians. Because of that, I am proceeding in the way that I am, which is the way that Dr Cass—now Baroness Cass—recommended.

  • 17 Dec 2025 · Puberty Suppressants Trial · Read the full contribution in Hansard
    More

    The risk that my hon. Friend sets out was one of the considerations that I had to when weigh up—first when upholding the temporary ban, and then when making the ban permanent. I do worry that, outside of a trial, we may continue to see unsafe or unethical practice.

  • 17 Dec 2025 · Puberty Suppressants Trial · Read the full contribution in Hansard
    More

    I absolutely agree with my hon. Friend that we need a strong evidence base, that we need to conduct these conversations with great care, consideration and compassion, and that we need to recognise the vulnerability of this particular group of children and young people, and the fear that so many trans people in our country feel about whether this is a country that accepts and respects them.

  • 17 Dec 2025 · Puberty Suppressants Trial · Hansard source
    More

    I can certainly give my hon. Friend that assurance.

  • 17 Dec 2025 · Puberty Suppressants Trial · Read the full contribution in Hansard
    More

    Let me just start by acknowledging the sensitivities around this issue and the strong beliefs held around this House. For all the division and divided opinion, I believe that there is a determination shared by everyone in this House to do the right thing by a vulnerable group of children and young people. It is for those reasons that I am taking the course of action that I am.

  • 17 Dec 2025 · Puberty Suppressants Trial · Read the full contribution in Hansard
    More

    I am grateful to the hon. Member for the way that she asks her question, as a critic of some of the decisions that I have taken in this space.

  • 17 Dec 2025 · Puberty Suppressants Trial · Read the full contribution in Hansard
    More

    I am grateful to my hon. Friend for that question. I recognise that the decision I took, within days of coming into this office, was received by trans people in particular, and the wider LGBT+ community, as a negative decision that detrimentally impacted their rights and identity. That is why it was an uncomfortable decision for me to take; I knew how it would be received and had to balance up the risk.

Explore activity by topic or department

Contributions by debate topic

4 Jul 2025–3 Jul 2026. Existing keyword taxonomy applied to official debate titles and contributions; a contribution may appear in more than one topic and unclassified records are retained.

View as listCommunities and local government: 35Communities and local government35Culture, media and sport: 12Culture, media and sport12Defence and foreign affairs: 9Defence and foreign affairs9Democracy and constitution: 24Democracy and constitution24Economy and business: 51Economy and business51Education and skills: 39Education and skills39Environment and energy: 5Environment and energy5Health and care: 242Health and care242Housing and planning: 13Housing and planning13Immigration and borders: 2Immigration and borders2Justice and policing: 9Justice and policing9Social security and pensions: 6Social security and pensions6Transport: 16Transport16Unclassified: 78Unclassified78
What this shows and doesn't show
4 Jul 2025–3 Jul 2026. Existing keyword taxonomy applied to official debate titles and contributions; a contribution may appear in more than one topic and unclassified records are retained. Published records do not measure effort or effectiveness. Methodology.
Department or topicPublished records
Communities and local government35
Culture, media and sport12
Defence and foreign affairs9
Democracy and constitution24
Economy and business51
Education and skills39
Environment and energy5
Health and care242
Housing and planning13
Immigration and borders2
Justice and policing9
Social security and pensions6
Transport16
Unclassified78

Published records only — not a full account of an MP’s work. How we work →